Allerspray-kids: medical device for the treatment of allergic rhinitis for children


Specially designed for children, ALLERSPRAY Kids acts quickly and easily against allergic rhinitis. It also protects the nasal mucosa from allergens by acting as a barrier. Clinical results show an improvement in all allergic rhinitis symptoms (nasal and ocular) after just 2 days of treatment.

Treatment of allergy symptoms in children

Understanding the needs of children, we’ve created Allerspray Kids – an osmotic film-forming nasal spray designed specifically for the little ones. Using the same innovative technology as our original Allerspray, Allerspray Kids provides effective relief from the symptoms of allergic rhinitis while being gentle on children’s delicate nasal tissues.


Unique Formulation

Allerspray Kids contains a specially adjusted formula suitable for children. It consists of the base ingredient, glycerol, combined with solagum and natural plant extracts, providing an osmotic, stable, and absorbent film barrier. This gentle yet effective formulation acts as an allergen shield, cleaning the nasal mucosa and offering immediate relief from symptoms.


Mode of action

The mechanical osmotic action cleans, protects and hydrates.  It thus promotes cell growth and repair. The polymers will also bind the target proteins.  The film is then naturally removed.

The mechanical osmotic action cleans, protects and hydrates. It thus promotes cell growth and repair. The polymers will also bind the target proteins. The film is then naturally removed.


Why Allerspray Kids

Allergies can seriously impair children’s quality of life, affecting their sleep, concentration and general well-being. Allerspray Kids has been designed to reduce these undesirable effects and alleviate the constant discomfort of allergic rhinitis.


Safe and Gentle

All the ingredients used in Allerspray Kids are food-grade and non-cytotoxic, ensuring safety for your child’s use. It does not have any cellular interaction, and all its effects are topical, meaning it’s not absorbed into the body but works mechanically on the nasal surface.


Effective Relief

Clinical results demonstrate that Allerspray Kids effectively reduces nasal congestion & irritation, helping to normalize nasal discharge in a short period. It offers a quick, soothing, and effective solution for children dealing with the distress of allergic rhinitis.


Safety & Efficacy

Allerspray Kids meets the Medical Device regulations, and all studies conducted prove its total safety and exclusively topical mode of action. Help your child breathe easier and enjoy their day with Allerspray Kids.

Understanding Pediatric Allergic Rhinitis

Allergic rhinitis (AR) represents a global health problem, affecting a substantial proportion of the pediatric population worldwide. It is an immunoglobulin E (IgE)-mediated inflammation of the nasal passages, typically triggered by airborne allergens.


Prevalence and Impact

Estimates suggest that AR affects 10% to 40% of children worldwide, making it one of the most common chronic diseases in the pediatric population. It has a considerable impact on the quality of life of affected children and their families, interfering with sleep, school performance, and overall daily activities.


Symptoms and Diagnosis

The symptoms of pediatric AR include sneezing, itching, nasal congestion, and clear nasal discharge. Diagnosis is typically based on a combination of a detailed medical history, physical examination, and, if necessary, specific allergy tests.


Treatment Challenges

Treatment of pediatric AR can pose unique challenges. Children may have difficulty tolerating certain treatment methods or may struggle with the proper use of medical devices. Moreover, the potential for systemic side effects and the need for long-term or frequent treatments make safety and tolerability key factors to consider when selecting a treatment option for pediatric AR.


The Need for Innovative Solutions

Given the prevalence and impact of AR in children, there is a need for effective, safe, and easy-to-use treatments. The development of innovative, child-friendly products that address the unique challenges of pediatric AR treatment is of high importance. Such solutions should prioritize safety, ease of use, and patient compliance while effectively addressing the symptoms and root causes of AR.


The Role of Allerspray Kids

The development of Allerspray Kids represents an important advancement in the field of pediatric AR treatment. This mechanical, non-invasive product helps to manage the symptoms of allergic rhinitis by creating an osmotic, stable, and absorbent film on the nasal mucosa, providing an instant protective barrier against environmental allergens. With its specifically designed formulation and mechanism of action, Allerspray Kids addresses the unique challenges of pediatric AR, offering a promising solution to improve the quality of life for affected children.



  • Mechanical mode of action
  • Instant osmotic action
  • Hydrates, protects and cleanses
  • Protects the nasal mucosa against allergens
  • Dual action: Relieves and protects
  • Significative reduction of allergic symptoms
  • Reduces nasal symptoms : congestion, rhinorrhea, sneezing, itching​
  • Reduces ocular symptoms : itching, tearing, redness​
  • Reduces the need for medication​
  • Improves quality of life​
  • No drowsiness (compared to the placebo group)​
  • Non-addictive​



General informations

Title : An Instant, Safe, Antihistamine, Anti-Inflammatory and Decongestant Polymeric Nasal Barrier to Prevent and To Treat Allergic Rhinitis in Children
Journal : Clinical Research and Clinical Trials  | 2021

TYPE OF TRIAL: Randomized, double-blind clinical trial against placebo | 2 weeks
PATIENTS: N=30 | Test product = 20 ; Comparator = 10
INCLUSION: Positive skin prick test for allergens and positive basophil count (>10 eosinophils/hpf)


Link to the publication





  • 36,46 % reduction in total nasal symptoms within 2 days.
  • 75,56 % reduction in total nasal symptoms within 7 days.
  • 96,24 % reduction in total nasal symptoms within 15 days.


  • 35,12 % reduction in ocular symptoms within 2 days.
  • 75,21 % reduction in ocular symptoms within 7 days.
  • 99,58 % reduction in ocular symptoms within 15 days


  • 73,24 % reduction in rhinorrhea within 7 days.
  • 66,67 % reduction in sneezing within 7 days.




IndicationFilmogen liquid bandage for the treatment of allergic rhinitis in children.
CompositionFilmogenic glycerol, solagum, water, association of Vaccinium myrtillus, Curcuma longa and Panax ginseng.
Conservatives : Potassium -Sodium - Acid citric.
PresentationNasal spray 15ml
ClassMDD Class I | MDR Class IIa
DirectionApply 2 sprays in each nostril, 2-3 times a day.
PrecautionsFor topical use only (nasal cavity).
Age 3+
Storage conditionsBelow 25°C
Legal manufacturer VITROBIO (France)
Product codeAEE